SYNOPSYS INC (SNPS) Insider Transactions
Explore official ownership filings, with every record linked to its source.
SNPS · SYNOPSYS INC
How to read this data ↗Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-10-15Filed 2026-10-16 | Ghazi SassineDirector · Officer · PRESIDENT AND CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $455.060 to $471.325. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 19, 2025. References: F2 | M Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 14,604D | 0 | Direct | Form 4 ↗0001822289-26-000012 |
| 2026-10-15Filed 2026-10-16 | Ghazi SassineDirector · Officer · PRESIDENT AND CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $455.060 to $471.325. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 19, 2025. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 14,604D | 462.843 | Direct | Form 4 ↗0001822289-26-000012 |
| 2026-10-15Filed 2026-10-16 | Ghazi SassineDirector · Officer · PRESIDENT AND CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $455.060 to $471.325. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 19, 2025. References: | M Exercise / conversionCommon Stock · Non-derivative | 14,604A | 135.88 | Direct | Form 4 ↗0001822289-26-000012 |
| 2026-10-06Filed 2026-10-07 | LEE JANETOfficer · GC & Corporate SecretaryFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $502.57 to $502.64. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. References: | S Sale (market/private)Common Stock · Non-derivative | 560D | 502.395 | Direct | Form 4 ↗0001711671-26-000026 |
| 2026-10-06Filed 2026-10-07 | LEE JANETOfficer · GC & Corporate SecretaryFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $502.57 to $502.64. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 583.607D | 502.6399 | Direct | Form 4 ↗0001711671-26-000026 |
| 2026-10-06Filed 2026-10-06 | Kankanwadi SudhindraOfficer · Deputy CFO & CAOFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | M Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 9,170D | 0 | Direct | Form 4 ↗0001652437-26-000010 |
| 2026-10-06Filed 2026-10-06 | Kankanwadi SudhindraOfficer · Deputy CFO & CAOFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | S Sale (market/private)Common Stock · Non-derivative | 9,170D | 500 | Direct | Form 4 ↗0001652437-26-000010 |
| 2026-10-06Filed 2026-10-06 | Kankanwadi SudhindraOfficer · Deputy CFO & CAOFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | M Exercise / conversionCommon Stock · Non-derivative | 9,170A | 135.88 | Direct | Form 4 ↗0001652437-26-000010 |
| 2026-10-05Filed 2026-10-06 | Kankanwadi SudhindraOfficer · Deputy CFO & CAOFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | M Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,000D | 0 | Direct | Form 4 ↗0001652437-26-000010 |
| 2026-10-05Filed 2026-10-06 | Kankanwadi SudhindraOfficer · Deputy CFO & CAOFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | S Sale (market/private)Common Stock · Non-derivative | 3,000D | 484.78 | Direct | Form 4 ↗0001652437-26-000010 |
| 2026-10-05Filed 2026-10-06 | Kankanwadi SudhindraOfficer · Deputy CFO & CAOFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | M Exercise / conversionCommon Stock · Non-derivative | 3,000A | 135.88 | Direct | Form 4 ↗0001652437-26-000010 |
| 2026-09-15Filed 2026-09-16 | Ghazi SassineDirector · Officer · PRESIDENT AND CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $371.995 to $379.990. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 19, 2025. References: F2 | M Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 14,604D | 0 | Direct | Form 4 ↗0001822289-26-000010 |
| 2026-09-15Filed 2026-09-16 | Ghazi SassineDirector · Officer · PRESIDENT AND CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $371.995 to $379.990. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 19, 2025. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 14,604D | 374.8756 | Direct | Form 4 ↗0001822289-26-000010 |
| 2026-09-15Filed 2026-09-16 | Ghazi SassineDirector · Officer · PRESIDENT AND CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $371.995 to $379.990. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 19, 2025. References: | M Exercise / conversionCommon Stock · Non-derivative | 14,604A | 135.88 | Direct | Form 4 ↗0001822289-26-000010 |
| 2026-09-11Filed 2026-09-14 | LEE JANETOfficer · GC & Corporate SecretaryFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 These shares were retained by the Company in order to meet the tax withholding obligations of the reporting person in connection with the vesting of an installment of the restricted stock unit award. The Compensation Committee approved the disposition of shares by the reporting person and the amount retained by the Company was not in excess of the amount of the tax liability. F2 Each stock unit converts into one share of Synopsys common stock. F3 33% of the units vest on the date shown followed by two equal annual installments, subject to continued service through each vesting date. References: F2, F3 | M Exercise / conversionRestricted Stock Units · Derivative | 2,283D | 0 | Direct | Form 4 ↗0001711671-26-000024 |
| 2026-09-11Filed 2026-09-14 | LEE JANETOfficer · GC & Corporate SecretaryFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 These shares were retained by the Company in order to meet the tax withholding obligations of the reporting person in connection with the vesting of an installment of the restricted stock unit award. The Compensation Committee approved the disposition of shares by the reporting person and the amount retained by the Company was not in excess of the amount of the tax liability. F2 Each stock unit converts into one share of Synopsys common stock. F3 33% of the units vest on the date shown followed by two equal annual installments, subject to continued service through each vesting date. References: F1 | F WithholdingCommon Stock · Non-derivative | 993D | 397.38 | Direct | Form 4 ↗0001711671-26-000024 |
| 2026-09-11Filed 2026-09-14 | LEE JANETOfficer · GC & Corporate SecretaryFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 These shares were retained by the Company in order to meet the tax withholding obligations of the reporting person in connection with the vesting of an installment of the restricted stock unit award. The Compensation Committee approved the disposition of shares by the reporting person and the amount retained by the Company was not in excess of the amount of the tax liability. F2 Each stock unit converts into one share of Synopsys common stock. F3 33% of the units vest on the date shown followed by two equal annual installments, subject to continued service through each vesting date. References: | M Exercise / conversionCommon Stock · Non-derivative | 2,283A | 0 | Direct | Form 4 ↗0001711671-26-000024 |
| 2026-09-01Filed 2026-09-02 | LEE JANETOfficer · GC & Corporate SecretaryFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 These shares were retained by the Company in order to meet the tax withholding obligations of the reporting person in connection with the vesting of an installment of the restricted stock unit award. The Compensation Committee approved the disposition of shares by the reporting person and the amount retained by the Company was not in excess of the amount of the tax liability. F2 Each stock unit converts into one share of Synopsys common stock. F3 The award vests on the date shown followed by quarterly installments, subject to continued service through each vesting date. References: F2, F3 | M Exercise / conversionRestricted Stock Units · Derivative | 699D | 0 | Direct | Form 4 ↗0001711671-26-000022 |
| 2026-09-01Filed 2026-09-02 | LEE JANETOfficer · GC & Corporate SecretaryFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 These shares were retained by the Company in order to meet the tax withholding obligations of the reporting person in connection with the vesting of an installment of the restricted stock unit award. The Compensation Committee approved the disposition of shares by the reporting person and the amount retained by the Company was not in excess of the amount of the tax liability. F2 Each stock unit converts into one share of Synopsys common stock. F3 The award vests on the date shown followed by quarterly installments, subject to continued service through each vesting date. References: F1 | F WithholdingCommon Stock · Non-derivative | 304D | 414.82 | Direct | Form 4 ↗0001711671-26-000022 |
| 2026-09-01Filed 2026-09-02 | LEE JANETOfficer · GC & Corporate SecretaryFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 These shares were retained by the Company in order to meet the tax withholding obligations of the reporting person in connection with the vesting of an installment of the restricted stock unit award. The Compensation Committee approved the disposition of shares by the reporting person and the amount retained by the Company was not in excess of the amount of the tax liability. F2 Each stock unit converts into one share of Synopsys common stock. F3 The award vests on the date shown followed by quarterly installments, subject to continued service through each vesting date. References: | M Exercise / conversionCommon Stock · Non-derivative | 699A | 0 | Direct | Form 4 ↗0001711671-26-000022 |
| 2026-09-01Filed 2026-09-02 | DE GEUS AARTDirector · Officer · EXECUTIVE CHAIRFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $435.88 to $445.70. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 Acquisition of stock under Synopsys, Inc Employee Stock Purchase Plan F3 Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $413.99 to $430.26. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. F4 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted October 14, 2025. References: F4 | M Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 24,641D | 0 | Direct | Form 4 ↗0001249802-26-000010 |
| 2026-09-01Filed 2026-09-02 | DE GEUS AARTDirector · Officer · EXECUTIVE CHAIRFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $435.88 to $445.70. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 Acquisition of stock under Synopsys, Inc Employee Stock Purchase Plan F3 Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $413.99 to $430.26. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. F4 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted October 14, 2025. References: F3 | S Sale (market/private)Common Stock · Non-derivative | 24,641D | 419.4401 | Direct | Form 4 ↗0001249802-26-000010 |
| 2026-09-01Filed 2026-09-02 | DE GEUS AARTDirector · Officer · EXECUTIVE CHAIRFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $435.88 to $445.70. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 Acquisition of stock under Synopsys, Inc Employee Stock Purchase Plan F3 Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $413.99 to $430.26. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. F4 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted October 14, 2025. References: | M Exercise / conversionCommon Stock · Non-derivative | 24,641A | 135.88 | Direct | Form 4 ↗0001249802-26-000010 |
| 2026-08-31Filed 2026-09-02 | Ghazi SassineDirector · Officer · PRESIDENT AND CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Acquisition of stock under Synopsys, Inc Employee Stock Purchase Plan References: F1 | J Other reported codeCommon Stock · Non-derivative | 27A | 360.961 | Direct | Form 4 ↗0001822289-26-000008 |
| 2026-08-31Filed 2026-09-02 | Kankanwadi SudhindraOfficer · Deputy CFO & CAOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Acquisition of stock under Synopsys, Inc Employee Stock Purchase Plan References: F1 | J Other reported codeCommon Stock · Non-derivative | 27A | 360.961 | Direct | Form 4 ↗0001652437-26-000008 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.